Last updated on July 2018

Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy


Brief description of study

The purpose of this study is evaluate the efficacy of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocation who have failed at least 1 previous treatment.

Clinical Study Identifier: NCT02924376

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center

Miami Beach, FL United States
2.25miles
  Connect »